Drug Database
Back to search

Belgium· BE-AMP-SAM660758-00

Daflon 500 mg

A diosmin, kombinationen product containing hesperidin, registered in Belgium by PI Pharma. The same ATC class is registered in 3 of our 19 countries.

ATC C05CA53

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDaflon 500 mgATCC05CA53REGISTER NO.BE-AMP-SAM660758-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hesperidinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diosmin, kombinationen is registered in 3 of 19 countries.

Countries holding a registration under ATC C05CA53 (diosmin, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search diosmin, kombinationen products by name

Diosmin, kombinationen · ATC C05CA53

3 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Hesperidin
Manufacturer
PI Pharma
Country
Belgium (BE)
ATC code
C05CA53
ATC class
Diosmin, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C05CA53

Diosmin, kombinationen, as other registers publish it.

All diosmin, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6fc76ab-b71f-48b2-859b-1211277de191
GET /v1/drugs/e6fc76ab-b71f-48b2-859b-1211277de191?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Daflon 500 mg",
  "name_fr": "Daflon 500 mg",
  "name_nl": "Daflon 500 mg",
  "amp_code": "SAM660758-00",
  "strengths": [
    "50.0000",
    "50.0000",
    "50.0000",
    "450.0000",
    "450.0000",
    "50.0000",
    "450.0000",
    "450.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Hesperidin",
    "Diosmin",
    "Glycerol",
    "Sodium Laurilsulfate",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diosmin, Combinations",
  "authorisation_numbers": [
    "1637PI0606F003"
  ]
}
API referenceMCP serverPlans

See everything about diosmin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console